LGR5 and cancer: To determine whether both Lgr5+ CSCs and Lgr5− cancer cells were able to enter the blood circulation, we drew blood from the portal vein of mice bearing metastatic CRC to analyze CTCs directly draining from the primary tumor using flow cytometry (Figure 3A; Figure S3A).